The Broad Foundation   Report issue

Academic/Hospital Phase 2
Founded: Los Angeles CA United States (1967)

Organization Overview

First Clinical Trial
2006
NCT00663117
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

The Broad Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Celiac Disease (Phase 2)

Crohn Disease (Phase 2)

Inflammation (Phase 2)

Pouchitis (Phase 2)

Vitamin D Deficiency (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 4